Vladimir Ponomarev

6.2k total citations · 2 hit papers
79 papers, 4.7k citations indexed

About

Vladimir Ponomarev is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Vladimir Ponomarev has authored 79 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 36 papers in Molecular Biology and 28 papers in Genetics. Recurrent topics in Vladimir Ponomarev's work include Virus-based gene therapy research (28 papers), CAR-T cell therapy research (27 papers) and Cancer Research and Treatments (11 papers). Vladimir Ponomarev is often cited by papers focused on Virus-based gene therapy research (28 papers), CAR-T cell therapy research (27 papers) and Cancer Research and Treatments (11 papers). Vladimir Ponomarev collaborates with scholars based in United States, Australia and Netherlands. Vladimir Ponomarev's co-authors include Ronald G. Blasberg, Inna Serganova, Mikhail Doubrovin, Michel Sadelain, Juri G. Gelovani, Julius Balatoni, Tatiana Beresten, Jelena Vider, Dilip D. Giri and William L. Gerald and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Vladimir Ponomarev

76 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Senolytic CAR T cells reverse senescence-associated pathologies

2020 724 citations Corina Amor, Judith Feucht et al. Nature profile →
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

2005 522 citations Andy J. Minn, Yibin Kang et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vladimir Ponomarev United States	35	2.0k	1.9k	951	921	818	79	4.7k
Irina V. Balyasnikova United States	36	1.4k 0.7×	1.9k 1.0×	902 0.9×	641 0.7×	915 1.1×	113	4.2k
Hrvoje Miletić Norway	40	1.1k 0.6×	2.5k 1.3×	707 0.7×	558 0.6×	390 0.5×	118	5.3k
Buck E. Rogers United States	40	2.0k 1.0×	1.8k 1.0×	546 0.6×	1.2k 1.3×	285 0.3×	126	5.0k
C. Ryan Miller United States	44	2.0k 1.0×	3.4k 1.8×	649 0.7×	1.6k 1.8×	383 0.5×	156	6.3k
John R. Ohlfest United States	36	1.7k 0.8×	1.5k 0.8×	1.5k 1.5×	511 0.6×	423 0.5×	65	4.2k
Inna Serganova United States	34	1.2k 0.6×	1.8k 0.9×	305 0.3×	646 0.7×	493 0.6×	65	3.5k
Alana L. Welm United States	41	2.4k 1.2×	4.0k 2.1×	799 0.8×	374 0.4×	486 0.6×	97	6.5k
Mikhail Doubrovin United States	26	1.2k 0.6×	1.4k 0.8×	548 0.6×	987 1.1×	424 0.5×	65	3.3k
Senthil K. Muthuswamy United States	46	4.4k 2.2×	6.3k 3.3×	890 0.9×	578 0.6×	700 0.9×	91	9.7k
Achim Temme Germany	36	1.5k 0.7×	2.3k 1.2×	1.1k 1.2×	463 0.5×	330 0.4×	105	4.4k

Countries citing papers authored by Vladimir Ponomarev

Since Specialization

Citations

This map shows the geographic impact of Vladimir Ponomarev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Ponomarev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Ponomarev more than expected).

Fields of papers citing papers by Vladimir Ponomarev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Ponomarev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Ponomarev. The network helps show where Vladimir Ponomarev may publish in the future.

Co-authorship network of co-authors of Vladimir Ponomarev

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Ponomarev. A scholar is included among the top collaborators of Vladimir Ponomarev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Ponomarev. Vladimir Ponomarev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volpe, Alessia, Serge K. Lyashchenko, & Vladimir Ponomarev. (2024). Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use. Molecular Imaging and Biology. 26(4). 555–568. 1 indexed citations

Skubal, Magdalena, Benedict Mc Larney, Alessia Volpe, et al.. (2024). Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies. Theranostics. 15(3). 766–783. 3 indexed citations

Luo, Dong, Xinning Wang, Gopalakrishnan Ramamurthy, et al.. (2023). Evaluation of a photodynamic therapy agent using a canine prostate cancer model. The Prostate. 83(12). 1176–1185. 4 indexed citations

Pratt, Edwin C., Alessia Volpe, Michael J. Crowley, et al.. (2023). Simultaneous quantitative imaging of two PET radiotracers via the detection of positron–electron annihilation and prompt gamma emissions. Nature Biomedical Engineering. 7(8). 1028–1039. 49 indexed citations

Moroz, Maxim A., Juan Zurita, Konstantin Dobrenkov, et al.. (2021). Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging. Molecular Therapy — Oncolytics. 21. 15–22. 10 indexed citations

Larrea, Carlos Fernández de, Mette Stæhr, Andrea V. Lopez, et al.. (2020). Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma. PubMed. 1(2). 146–154. 147 indexed citations

Amor, Corina, Judith Feucht, Josef Leibold, et al.. (2020). Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 583(7814). 127–132. 724 indexed citations breakdown →

Hoseini, Sayed Shahabuddin, et al.. (2019). Silencing Fc Domains in T cell–Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunology Research. 7(12). 2013–2024. 51 indexed citations

Krebs, Simone, Vladimir Ponomarev, Susan F. Slovin, & Heiko Schöder. (2019). Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction. Journal of Nuclear Medicine. 60(7). 879–881. 11 indexed citations

10.

Dao, Tao, Dmitry Pankov, Andrew Scott, et al.. (2015). Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. 33(10). 1079–1086. 126 indexed citations

11.

Serganova, Inna, Vladimir Ponomarev, & Ronald G. Blasberg. (2012). Radionuclide-based reporter gene imaging: pre-clinical and clinical implementation and application. Nuclear Medicine Review. 15. 20–36. 5 indexed citations

12.

Das, Suvendu, Simona Podgrabinska, Vladimir Ponomarev, et al.. (2010). Vascular Endothelial Growth Factor-C Induces Lymphangitic Carcinomatosis, an Extremely Aggressive Form of Lung Metastases. Cancer Research. 70(5). 1814–1824. 35 indexed citations

13.

Zinonos, Irene, Agatha Labrinidis, Michelle Lee, et al.. (2009). Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer. Molecular Cancer Therapeutics. 8(10). 2969–2980. 37 indexed citations

14.

Klose, Alexander D., Bradley J. Beattie, Hamid Dehghani, et al.. (2009). In vivo bioluminescence tomography with a blocking‐off finite‐difference method and MRI/CT coregistration. Medical Physics. 37(1). 329–338. 65 indexed citations

15.

Ponomarev, Vladimir. (2009). Nuclear Imaging of Cancer Cell Therapies. Journal of Nuclear Medicine. 50(7). 1013–1016. 21 indexed citations

16.

Gade, T., Jason A. Koutcher, William M. Spees, et al.. (2008). Imaging Transgene Activity In vivo. Cancer Research. 68(8). 2878–2884. 14 indexed citations

17.

Stephan, Matthias T., Vladimir Ponomarev, Renier J. Brentjens, et al.. (2007). T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine. 13(12). 1440–1449. 237 indexed citations

18.

Minn, Andy J., Yibin Kang, Inna Serganova, et al.. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. Journal of Clinical Investigation. 115(1). 44–55. 522 indexed citations breakdown →

19.

Месяц, Г. А., et al.. (1978). Volume discharge in a gas, excited by an electron beam under conditions of nonuniform ionization. NASA STI/Recon Technical Report N. 3. 357.

20.

Mesyats, G. A., et al.. (1974). Field distribution in a gas discharge excited by fast electrons. Soviet physics. Technical physics. 18. 1478.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact